Widespread use of statins for primary prevention could reduce risk of vascular events

Even patients with a 5-year risk for major vascular events <10% may benefit from primary prevention using statin therapy, according to the results of a large meta-analysis.

This study may hold particular significance for patients in India, where genetic susceptibility results in a higher rate of vascular events, and where the World Health Organization predicts that cardiovascular diseases (CVD) will be the largest cause of...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Cardiovascular, Non-Communicable Disease, Non-Communicable Disease Featured 2, Primary Care and tagged , , , , , , , , , , , . Volume: .

One Comment